Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Life Sciences Vital Fluids | | | | | | 1.7 | 19.7 | 17.2 |
Revenues | | | | | | 1.7 | 19.7 | 17.2 |
Revenue growth [+] | | | | | | -91.5% | 14.6% | 1.9% |
Life Sciences Vital Fluids | | | | | | -91.5% | 14.6% | 1.9% |
EBITDA | | | | | | 0.2 | 2.4 | 1.4 |
EBITDA margin | | | | | | 9.8% | 12.1% | 8.0% |
Depreciation and amortization | | | | | | 0.0 | 0.8 | 0.6 |
EBIT | | | | | | 0.1 | 1.6 | 0.8 |
EBIT margin | | | | | | 7.1% | 8.0% | 4.5% |
|
Capital expenditures | | | | | | 0.0 | 0.6 | 0.2 |
|
Total assets | | | | | | | 11.6 | 11.9 |
ROA | | | | | | | 8.9% | 4.4% |
|
Revenue Mix | | | | | | 0.3% | 3.7% | 4.3% |
EBIT Mix | | | | | | 0.2% | 4.6% | 2.7% |
|